title: Persistent mobility disability after neurotoxic chemotherapy.
abstract: OBJECTIVE
  The impact of cancer and its treatments on balance and functional mobility in older adults remains unknown but is increasingly important, given the evolution of cancer treatments. Subacute and more persistent side effects such as chemotherapy-induced peripheral neuropathy are on the rise, and the effects on mobility and balance, as well as the prognosis for resolution of any functional deficits, must be established before interventions can be trialed. The purpose of this case report is to describe the severity and long-term persistence of mobility decline in an older adult who received neurotoxic chemotherapy. To our knowledge, this is the first case report to describe an older adult with chemotherapy-induced peripheral neuropathy using results of standardized balance and mobility tests and to focus on prognosis by repeating these measures more than 2 years after chemotherapy.
  
  
  METHODS
  An 81-year-old woman received a neurotoxic agent (paclitaxel) after curative mastectomy for breast cancer. Baseline testing prior to taxane therapy revealed a socially active woman with no reported functional deficits or neuropathic symptoms, 1.2-m/s gait speed, and performance at the ceiling on balance and gait portions of a standardized mobility measure.
  
  
  RESULTS
  After 3 cycles, paclitaxel therapy was stopped by the oncologist because of neurotoxicity. Declines as large as 50% were seen in performance-based measures at 12 weeks and persisted at 2.5 years, and the patient reported recurrent falls, cane use, and mobility-related disability.
  
  
  CONCLUSIONS
  This case highlights the extent to which function can decline in an older individual receiving neurotoxic chemotherapy, the potential for these deficits to persist years after treatment is stopped, and the need for physical therapy intervention and further research in this population.
authors.affiliation: Department of Physical Therapy, School of Health and Rehabilitation Sciences, University of Pittsburgh, 6035 Forbes Tower, Pittsburgh, PA 15260, USA. ehile@pitt.edu
authors.forename: Elizabeth S
authors.initials: ES
authors.lastname: Hile
authors.forename: G Kelley
authors.initials: GK
authors.lastname: Fitzgerald
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Studenski
mesh_terms: D000369:Aged, 80 and over; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D004185:Disability Evaluation; D005260:Female; D020233:Gait Disorders, Neurologic / Q000139:chemically induced*; D006801:Humans; D008408:Mastectomy; D051346:Mobility Limitation; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D004856:Postural Balance / Q000187:drug effects
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel
references.citation: J Psychiatr Res. 1975 Nov;12(3):189-98
references.pmid: 1202204
references.citation: Support Care Cancer. 1999 Sep;7(5):354-61
references.pmid: 10483822
references.citation: J Am Geriatr Soc. 1991 Feb;39(2):142-8
references.pmid: 1991946
references.citation: J Am Board Fam Pract. 2004 Sep-Oct;17(5):309-18
references.pmid: 15355943
references.citation: J Clin Oncol. 1994 Feb;12(2):241-8
references.pmid: 7509380
references.citation: Arch Phys Med Rehabil. 2007 Aug;88(8):1002-8
references.pmid: 17678662
references.citation: J Gerontol. 1994 Mar;49(2):M85-94
references.pmid: 8126356
references.citation: J Am Geriatr Soc. 2003 Mar;51(3):314-22
references.pmid: 12588574
references.citation: J Neurooncol. 1997 Oct;35(1):47-53
references.pmid: 9266440
references.citation: J Am Acad Nurse Pract. 2004 Aug;16(8):353-9
references.pmid: 15455708
references.citation: J Clin Oncol. 1994 Nov;12(11):2447-52
references.pmid: 7964962
references.citation: J Peripher Nerv Syst. 2000 Dec;5(4):191-208
references.pmid: 11151980
references.citation: J Gerontol A Biol Sci Med Sci. 2000 Apr;55(4):M221-31
references.pmid: 10811152
references.citation: J Clin Oncol. 2005 May 1;23(13):3112-24
references.pmid: 15860871
references.citation: Proc R Soc Med. 1965 May;58:295-300
references.pmid: 14283879
references.citation: JAMA. 1989 May 12;261(18):2663-8
references.pmid: 2709546
references.citation: Curr Med Chem. 2008;15(29):3081-94
references.pmid: 19075655
references.citation: BMC Cancer. 2006 Jan 07;6:5
references.pmid: 16398939
references.citation: Support Care Cancer. 2005 Aug;13(8):647-51
references.pmid: 15711945
references.citation: Ann Oncol. 1998 Jul;9(7):739-44
references.pmid: 9739440
references.citation: Pain. 2004 May;109(1-2):132-42
references.pmid: 15082135
references.citation: J Am Geriatr Soc. 2006 May;54(5):743-9
references.pmid: 16696738
references.citation: J Neurol. 1992 Apr;239(4):199-204
references.pmid: 1317914
references.citation: Neurology. 2003 Jan 28;60(2):337-40
references.pmid: 12552058
references.citation: Vital Health Stat 1. 1987 Jun;(21):1-115
references.pmid: 3672938
references.citation: J Am Geriatr Soc. 1994 Jul;42(7):743-9
references.pmid: 8014350
references.citation: Cancer. 1997 Nov 15;80(10):1973-80
references.pmid: 9366301
references.citation: J Gerontol A Biol Sci Med Sci. 2003 Dec;58(12):M1119-24
references.pmid: 14684709
references.citation: J Gerontol. 1994 May;49(3):M97-108
references.pmid: 8169338
references.citation: Lancet. 2005 Jan 1-7;365(9453):60-2
references.pmid: 15639680
references.citation: Semin Neurol. 2005 Jun;25(2):204-16
references.pmid: 15937736
references.citation: Neurology. 2005 Mar 22;64(6):1076-7
references.pmid: 15781834
references.citation: Phys Ther. 2009 Mar;89(3):286-306
references.pmid: 19147708
references.citation: J Clin Oncol. 2006 Jul 20;24(21):3465-73
references.pmid: 16849763
references.citation: Clin J Oncol Nurs. 2007 Dec;11(6):901-13
references.pmid: 18063548
references.citation: Curr Neurol Neurosci Rep. 2008 Jan;8(1):56-65
references.pmid: 18367040
references.citation: Ital J Neurol Sci. 1997 Apr;18(2):73-9
references.pmid: 9239526
references.citation: Clin J Oncol Nurs. 2005 Apr;9(2):189-93
references.pmid: 15853162
references.citation: Support Care Cancer. 2006 Mar;14(3):223-9
references.pmid: 16021477
references.citation: N Engl J Med. 1995 Mar 2;332(9):556-61
references.pmid: 7838189
references.citation: Acta Otorhinolaryngol Ital. 2008 Oct;28(5):239-42
references.pmid: 19186452